• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    6/14/23 1:13:07 PM ET
    $AKU
    $AY
    $BENF
    $BIOC
    Medical Specialities
    Health Care
    Electric Utilities: Central
    Utilities
    Get the next $AKU alert in real time by email

     

    On Wednesday, 33 stocks hit new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was UnitedHealth Group (NYSE:UNH).
    • Biocept (NASDAQ:BIOC) was the smallest, in terms of market cap, to set a new 52-week low.
    • Tenon Medical (NASDAQ:TNON) shares traded down 51.96% to reach its 52-week low, making it the biggest loser.
    • Camber Energy (AMEX:CEI) shares actually gained 0.16%, rebounding after it reached its 52-week low.

    The stocks that set new 52-week lows on Wednesday:

    • UnitedHealth Group (NYSE:UNH) stock dropped to a yearly low on Wednesday of $445.83. Shares traded down 7.25%.
    • Atlantica Sustainable (NASDAQ:AY) stock drifted down 1.08% on Wednesday morning to hit a new 52-week low of $23.70.
    • Beneficient (NASDAQ:BENF) stock set a new 52-week low of $5.21 on Wednesday, moving down 7.19%.
    • PolyMet Mining (AMEX:PLM) shares hit a yearly low of $0.82. The stock was up 0.22% on the session.
    • Intevac (NASDAQ:IVAC) stock drifted down 13.84% on Wednesday morning to hit a new 52-week low of $3.68.
    • Precision BioSciences (NASDAQ:DTIL) shares hit a yearly low of $0.66. The stock was down 3.52% on the session.
    • Mullen Automotive (NASDAQ:MULN) shares made a new 52-week low of $0.27 on Wednesday. The stock was down 12.88% for the day.
    • FLJ Group (NASDAQ:FLJ) shares hit a yearly low of $0.28. The stock was down 13.73% on the session.
    • Great Elm Capital (NASDAQ:GECC) shares made a new 52-week low of $7.55 on Wednesday. The stock was down 3.5% for the day.
    • Passage Bio (NASDAQ:PASG) shares set a new 52-week low of $0.93. The stock traded down 0.75%.
    • IO Biotech (NASDAQ:IOBT) shares hit a yearly low of $1.58. The stock was down 19.66% on the session.
    • Upexi (NASDAQ:UPXI) shares set a new yearly low of $2.04 this morning. The stock was down 6.74% on the session.
    • Trio Petroleum (AMEX:TPET) stock hit $1.30 on Wednesday morning, setting a new 52-week low for a change of down 2.96%.
    • Akumin (NASDAQ:AKU) shares reached a new 52-week low of $0.33 on Wednesday morning, moving up 2.19%.
    • Castellum (AMEX:CTM) shares fell to $0.56 on Wednesday, setting a new 52-week low with a shift of down 4.72%.
    • Camber Energy (AMEX:CEI) stock hit a new 52-week low of $1.00. The stock was up 0.16% on the session.
    • iClick Interactive Asia (NASDAQ:ICLK) stock hit $2.05 on Wednesday morning, setting a new 52-week low for a change of down 4.66%.
    • Cineverse (NASDAQ:CNVS) stock hit $2.20 on Wednesday morning, setting a new 52-week low for a change of down 35.53%.
    • SMX (Security Matters) (NASDAQ:SMX) shares fell to $0.62 on Wednesday, setting a new 52-week low with a shift of down 17.84%.
    • Bluejay Diagnostics (NASDAQ:BJDX) stock hit a yearly low of $0.19. The stock was down 4.55% for the day.
    • OceanPal (NASDAQ:OP) shares reached a new 52-week low of $2.53 on Wednesday morning, moving down 7.66%.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new yearly low of $0.59 this morning. The stock was up 1.37% on the session.
    • INVO Bioscience (NASDAQ:INVO) stock hit a yearly low of $0.15. The stock was down 5.27% for the day.
    • Biocept (NASDAQ:BIOC) stock set a new 52-week low of $1.64 on Wednesday, moving down 2.58%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AKU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKU
    $AY
    $BENF
    $BIOC

    CompanyDatePrice TargetRatingAnalyst
    IO Biotech Inc.
    $IOBT
    1/26/2026$0.50Overweight → Neutral
    Piper Sandler
    IO Biotech Inc.
    $IOBT
    1/8/2026$0.36Equal-Weight → Underweight
    Morgan Stanley
    UnitedHealth Group Incorporated
    $UNH
    10/29/2025$333.00Buy → Hold
    Deutsche Bank
    UnitedHealth Group Incorporated
    $UNH
    10/14/2025$406.00Buy
    Goldman
    IO Biotech Inc.
    $IOBT
    9/30/2025$0.39Overweight → Equal-Weight
    Morgan Stanley
    IO Biotech Inc.
    $IOBT
    9/30/2025Buy → Hold
    TD Cowen
    Upexi Inc.
    $UPXI
    8/4/2025$15.00Buy
    Alliance Global Partners
    UnitedHealth Group Incorporated
    $UNH
    7/31/2025$198.00Neutral → Underperform
    Robert W. Baird
    More analyst ratings

    $AKU
    $AY
    $BENF
    $BIOC
    SEC Filings

    View All

    Upexi Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - UPEXI, INC. (0001775194) (Filer)

    1/30/26 5:05:40 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 8-K filed by IO Biotech Inc.

    8-K - IO Biotech, Inc. (0001865494) (Filer)

    1/30/26 4:53:41 PM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bluejay Diagnostics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Bluejay Diagnostics, Inc. (0001704287) (Filer)

    1/29/26 9:14:31 PM ET
    $BJDX
    Medical/Dental Instruments
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Marshall Allan bought $90,000 worth of shares (50,000 units at $1.80), increasing direct ownership by 1% to 4,046,261 units (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    12/23/25 7:53:48 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Executive Officer Marshall Allan was granted 1,600,000 shares and bought $310,500 worth of shares (150,000 units at $2.07), increasing direct ownership by 78% to 3,996,261 units (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    12/17/25 6:43:21 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Germano Geno J bought $14,160 worth of shares (3,000 units at $4.72), increasing direct ownership by 14% to 23,883 units (SEC Form 4)

    4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)

    12/17/25 7:02:05 AM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IO Biotech Provides Corporate Update

    Raymond James engaged as financial advisorReduction in force implemented NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that it has retained Raymond James & Associates, Inc. to serve as exclusive financial advisor to assist the company in its previously announced exploration of strategic alternatives. The company also announced that it is implementing cost-containment and cash conservation measures, including a significant reduction of the company's workforce, to reduce operating expenses while the company explores strategic al

    1/30/26 8:05:00 AM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cineverse Announces Blood-Curdling New Programming for Horror Streamer SCREAMBOX

    Kicking off with the return of 'Bloody Bites' for its 16th season LOS ANGELES, Jan. 29, 2026 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, and Bloody Disgusting, its horror division, have announced their upcoming slate of programming coming to its SCREAMBOX streaming service. This announcement comes as SCREAMBOX continues to grow – as of December 2025, SCREAMBOX subscribers were up +18% year-over-year. In fact, this has driven growth for Cineverse's overall streaming channels business, which has seen subscribers increase +13% YOY with subscr

    1/29/26 3:00:00 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Upexi to Host Second Quarter 2026 Earnings Call on February 10th at 5:30 p.m. ET

    TAMPA, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it plans to host a conference call and report its financial results for the second quarter 2026 ended December 31, 2025, on Tuesday, February 10, 2026. Additional details are available under the Investor Relations section of the Company's website: https://ir.upexi.com/ Event:Upexi Second Quarter 2026 Earnings CallDate:Tuesday, February 10, 2026Time:5:30 p.m. ETLive Call:1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International)Webcasthttps://ir.upexi.com/news-events/ir-calendar For

    1/29/26 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    IO Biotech downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded IO Biotech from Overweight to Neutral and set a new price target of $0.50

    1/26/26 10:01:23 AM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IO Biotech downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded IO Biotech from Equal-Weight to Underweight and set a new price target of $0.36

    1/8/26 8:40:06 AM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UnitedHealth downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded UnitedHealth from Buy to Hold and set a new price target of $333.00

    10/29/25 7:53:31 AM ET
    $UNH
    Medical Specialities
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Amoroso Michael converted options into 115,378 shares and sold $145,112 worth of shares (34,799 units at $4.17), increasing direct ownership by 70% to 196,154 units (SEC Form 4)

    4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)

    1/22/26 6:49:01 PM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    General Counsel and Secretary Scimeca Dario converted options into 25,311 shares and sold $35,682 worth of shares (8,854 units at $4.03), increasing direct ownership by 58% to 44,715 units (SEC Form 4)

    4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)

    1/22/26 6:48:49 PM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Financial Officer Kelly John Alexander converted options into 44,363 shares and sold $61,308 worth of shares (15,213 units at $4.03), increasing direct ownership by 38% to 106,448 units (SEC Form 4)

    4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)

    1/22/26 6:48:36 PM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Leadership Updates

    Live Leadership Updates

    View All

    Cineverse and GameStop Invite Fans to 'Return to Silent Hill' with Innovative Partnership featuring Mysterious Messages, Exclusive Rewards, In-Store Media & More

    Return to Silent Hill Hits Theaters Nationwide on January 23 – Buy Tickets Now LOS ANGELES and GRAPEVINE, Texas, Jan. 14, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next generation entertainment studio, and GameStop Corp. (NYSE:GME), are pulling out all the stops in anticipation of the January 23 wide theatrical release of Return to Silent Hill (returntosilenthillmovie.com).  The two companies are collaborating on an immersive marketing campaign for the new film, based on the visionary video game, SILENT HILL 2. Since January 7, fans who visit a participating GameStop ca

    1/14/26 3:02:00 PM ET
    $CNVS
    $GME
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Electronics Distribution

    Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board

    DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the "Board") has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee since 2019. He brings decades of leadership experience in financial reporting, accounting, and corporate governance within the financial services industry. Mr. Cangany retired as a partner

    12/17/25 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    Upexi Welcomes Jon Najarian to the Upexi Advisory Committee

    TAMPA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, today announced the addition of Jon Najarian (Twitter: @jonnajarian) to the Upexi Advisory Committee, joining Arthur Hayes and S◎L Big Brain as founding Upexi Advisory Committee members. Jon Najarian is a highly influential figure in the world of finance, renowned for his deep expertise in options trading and market strategy. A former professional football player, Jon co-founded options trading firm Mercury Trading and later launched financial education company Marke

    10/23/25 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Financials

    Live finance-specific insights

    View All

    Upexi to Host Second Quarter 2026 Earnings Call on February 10th at 5:30 p.m. ET

    TAMPA, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it plans to host a conference call and report its financial results for the second quarter 2026 ended December 31, 2025, on Tuesday, February 10, 2026. Additional details are available under the Investor Relations section of the Company's website: https://ir.upexi.com/ Event:Upexi Second Quarter 2026 Earnings CallDate:Tuesday, February 10, 2026Time:5:30 p.m. ETLive Call:1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International)Webcasthttps://ir.upexi.com/news-events/ir-calendar For

    1/29/26 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    UnitedHealth Group Reports 2025 Results and Issues 2026 Outlook

    Full Year 2025 Revenues of $447.6 Billion Grew 12% Year-Over-Year; Earnings of $13.23 Per Share; Adjusted Earnings of $16.35 Per Share Full Year 2026 Revenue Outlook Greater Than $439.0 Billion; Earnings Outlook Greater Than $17.10 Per Share; Adjusted Earnings Greater Than $17.75 Per Share To view this information in a different format, including graphics, published on our website, click here: https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2025/unh-reports-2025-results-and-issues-2026-outlook.pdf. UnitedHealth Group (NYSE:UNH) today reported full year and fourth quarter 2025 results and issued its 2026 outlook. This press release features multimedia. View the full

    1/27/26 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    Cineverse Acquires Giant Worldwide and Integrates Service into Matchpoint™ Platform, Bringing Deep Studio Relationships into Its Automated Media Services Ecosystem

    Acquisition Brings Giant's Existing Clients – Including the World's Top Movie Studios, Networks and Leading Entertainment Companies – to Cineverse's Matchpoint™ Ecosystem LOS ANGELES, Jan. 7, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next-generation entertainment studio, today announced the acquisition of Giant Worldwide, a global media services provider serving the world's leading Hollywood studios and streaming platforms. Thanks to this strategic acquisition, Matchpoint™—the Company's award-winning, AI-powered media supply chain solution—solidifies its role as the lea

    1/7/26 11:00:00 AM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AKU
    $AY
    $BENF
    $BIOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Great Elm Capital Corp.

    SC 13D/A - Great Elm Capital Corp. (0001675033) (Subject)

    12/13/24 6:47:34 PM ET
    $GECC
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Atlantica Sustainable Infrastructure plc

    SC 13D/A - Atlantica Sustainable Infrastructure plc (0001601072) (Subject)

    12/12/24 12:30:42 PM ET
    $AY
    Electric Utilities: Central
    Utilities

    SEC Form SC 13G filed by Great Elm Capital Corp.

    SC 13G - Great Elm Capital Corp. (0001675033) (Subject)

    12/12/24 8:44:54 AM ET
    $GECC
    Finance: Consumer Services
    Finance